Skip to main navigation Skip to search Skip to main content

Coidentification of mcr-4.3 and blaNDM-1 in a clinical enterobacter cloacae isolate from China

  • Bhakti Chavda
  • , Jingnan Lv
  • , Mengyun Hou
  • , Kalyan D. Chavda
  • , Barry N. Kreiswirth
  • , Youjun Feng
  • , Liang Chen
  • , Fangyou Yu
  • Rutgers - The State University of New Jersey, Newark
  • Wenzhou Medical University
  • Zhejiang University
  • Tongji University

Research output: Contribution to journal › Article › peer-review

48 Scopus citations

Abstract

We describe the first report of a clinical colistin-resistant ST84 Enterobacter cloacae isolate coharboring mcr-4.3 (previously named mcr-4.2) and blaNDM-1 from a patient in China. The blaNDM-1-harboring IncX3 plasmid and the novel mcr-4.3-harboring ColE plasmid were completely sequenced. Although this isolate showed a high level of resistance to colistin, mcr-4.3 plasmid transformation, gene subcloning, susceptibility testing, and lipid A matrix-assisted laser desorption ionization mass spectrometry analysis indicated that mcr-4.3 itself does not confer resistance to colistin.

Original languageEnglish
Article numbere00649
JournalAntimicrobial Agents and Chemotherapy
Volume62
Issue number10
DOIs
StatePublished - Oct 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Carbapenem resistant
  • Colistin
  • Mcr-4
  • NDM-1
  • Plasmid

Fingerprint

Dive into the research topics of 'Coidentification of mcr-4.3 and blaNDM-1 in a clinical enterobacter cloacae isolate from China'. Together they form a unique fingerprint.

Cite this